3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Dermatologic
1
Conditions
Keratosis, Actinic
2
Keratosis
2
Precancerous Conditions
1
Neoplasms
1
Interventions
fludarabine phosphate
3
Whole-Body Irradiation
3
Tacrolimus
3
Peripheral Blood Stem Cell Transplantation
3
Mycophenolic Acid
3
Melphalan
3
Cyclophosphamide
3
Busulfan
3
Biopsy
3
fludarabine
2
Patient Reported Outcome Measures
2
Mesna
2
Colposcopy
2
Aminolevulinic Acid
2
tirbanibulin
1
ruxolitinib
1
Watchful Waiting
1
Transurethral Resection of Prostate
1
Thalidomide
1
Tamoxifen
1
Sirolimus
1
Robotic Surgical Procedures
1
Radiotherapy, Intensity-Modulated
1
Pregnancy Tests
1
Nivolumab
1
Methotrexate
1
Immunohistochemistry
1
Hysterectomy
1
Human Papillomavirus DNA Tests
1
Etoposide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Precancerous Conditions
×
tirbanibulin
×
1 year
×
Clear all
NCT06135415
2026-03-25
TirbAKare
Almirall, S.A.
Phase 3
Completed
280 enrolled